EDNA Wellness
El costo de la terapia con células madre para la ELA en Tailandia suele oscilar de $25,000 / 925,000฿ a $45,000 / 1,665,000฿. Los precios pueden variar según la clínica, la experiencia del equipo médico, el tipo y número de infusiones de células madre y si se incluyen terapias de apoyo adicionales. En Estados Unidos, el costo promedio es $165,000 / 6,105,000฿. Esto significa que la terapia con células madre para la ELA en Tailandia es aproximadamente un 79% menos costosa que en EE. UU.
En Tailandia, el precio cotizado normalmente cubre la consulta inicial, análisis de laboratorio previos al tratamiento, recolección y procesamiento de células madre, varias sesiones de infusión, estancia hospitalaria y visitas de seguimiento. En EE. UU., los costos suelen incluir solo el procedimiento en sí, con cargos separados por consultas, análisis de laboratorio, tarifas hospitalarias y cuidados posteriores. Siempre confirmar exactamente qué incluye cada clínica en su paquete.
| Tailandia | España | Turquía | |
| Terapia con células madre para la ELA (esclerosis lateral amiotrófica) | de $25,000 / 925,000฿ | de $40,000 / 1,480,000฿ | de $30,000 / 1,110,000฿ |
Bookimed no añade cargos adicionales a los precios de Terapia con células madre para la ELA (esclerosis lateral amiotrófica). Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su Terapia con células madre para la ELA (esclerosis lateral amiotrófica) a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en Terapia con células madre para la ELA (esclerosis lateral amiotrófica) y tienen las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después del tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de Terapia con células madre para la ELA (esclerosis lateral amiotrófica).
Especializado en Medicina Regenerativa con certificación del American Board of Regenerative Medicine – el Dr. Chollawat lidera la investigación de células madre en Vega Clinic.
Doctor en Osteopatía con certificaciones internacionales en osteopatía y medicina tradicional china – Gerald Raphael Tur aporta un enfoque holístico a la atención de la ELA en la Clínica Vega.
Stem cell therapy for ALS in Thailand is an experimental treatment. It is not a standard medical protocol. Private clinics in Bangkok provide these therapies. However, they remain outside conventional medical channels. Safety is generally high in ISO-certified facilities. These clinics use mesenchymal stem cells to minimise rejection risks.
Bookimed Expert Insight: Many countries lack clear pathways for these treatments. Thailand allows private clinics to offer them under strict laboratory standards. Verification is key. Facilities with ISO/IEC 17025:2017 accreditation offer reliable quality control for Australians seeking experimental options.
Patient Consensus: Treatment in Thailand is seen as an experimental step. It requires deep research into clinical protocols. Patients suggest choosing centres with transparent follow-up plans. They also recommend looking for documented results from previous cases.
Stem cell therapy for ALS in Thailand uses mesenchymal stem cells (MSCs) to slow disease progression. These treatments aim to improve quality of life. Specialists use intravenous or intrathecal injections to reduce inflammation and support motor neurons. Treatment typically occurs in JCI or ISO-accredited clinics in Bangkok.
Bookimed Expert Insight: Many clinics offer general stem cell treatments. However, the most reliable outcomes for neurological conditions in Thailand come from centres partnering with TISTR. These partnerships help laboratory-grown cells meet strict OECD Good Laboratory Practice standards.
Patient Consensus: Patients suggest asking for exact cell dosages. They also advise separating the benefits of bundled intensive physiotherapy from the stem cell results. They recommend coordinating with a local neurologist before travelling to Thailand for a cohesive care plan.
Patients should expect stem cell therapy for ALS in Thailand to function as a supportive treatment rather than a cure. The procedure aims to slow disease progression and improve quality of life. Realistically, outcomes include stabilised motor function, improved facial muscle strength, and temporary gains in breathing capacity.
Bookimed Expert Insight: The primary goal is slowing progression. Thailand stands out because doctors like Dr Chollawat Thongthaisin hold American Board of Regenerative Medicine certification. This helps patients follow international protocols. However, treatments in Thailand cost between $25,000 and $45,000. This is higher than the $30,300 Australian average. The premium pays for laboratory partnerships and board-certified specialists.
Patient Consensus: Patients in Thailand report that while recovery is not the reality, the treatment can offer modest slowing of the disease. They suggest prioritising rest. Both the travel and procedure are physically taxing for individuals with ALS.
Several Bangkok medical facilities specialise in stem cell therapy for ALS. These centres focus on regenerative medicine to support neurological function. EDNA Wellness and Vega Clinic are notable for their lab partnerships and board-certified experts. They provide tailored mesenchymal stem cell protocols within internationally recognised safety frameworks.
Bookimed Expert Insight: While mainstream hospitals cost upwards of $45,000, labs partnering with EDNA Wellness provide same-day processing. This direct lab-to-clinic pathway maintains higher cell viability. This is critical for patients travelling from Australia.
Patient Consensus: Patients in Bangkok often use protocols involving both local injections and intranasal administration. This allows for better neural access. Many recommend requesting peer-reviewed data and exact cell counts before starting any regenerative therapy program.